| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/13/2005 | EP1551425A2 Therapeutic formulations |
| 07/13/2005 | EP1551417A2 Three layer tear formulation |
| 07/13/2005 | EP1551416A2 Method for treating erectile dysfunction and increasing libido in men |
| 07/13/2005 | EP1551402A2 Abuse-resistant pharmaceutical compositions |
| 07/13/2005 | EP1551399A1 Method for topical treatment of eye disease and composition and device for said treatment |
| 07/13/2005 | EP1551391A1 Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid |
| 07/13/2005 | EP1551390A1 Levamisole, avermectins or similar in pyrrolidone solvent |
| 07/13/2005 | EP1551376A2 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/13/2005 | EP1551371A2 Stabilized nanoparticle formulations of camptotheca derivatives |
| 07/13/2005 | EP1551370A1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 07/13/2005 | EP1551368A1 Controlled release of anti-arrhythmic agents |
| 07/13/2005 | EP1551367A2 Breath freshening and oral cleansing product with cinnamaldehyde |
| 07/13/2005 | EP1551364A1 Thickener compositions comprising sclerotium gum and a copolymer |
| 07/13/2005 | EP1551330A1 Improvements in delivery technology |
| 07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |
| 07/13/2005 | EP1248636B1 Dextrin containing compositions for prevention of adhesions |
| 07/13/2005 | EP1207860A4 Controlled release pellet formulation |
| 07/13/2005 | EP1202722B1 Uses of compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1639228A Carbohydrate-modified polymers, compositions and uses related thereto |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1638819A Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/13/2005 | CN1638809A Coupling low-molecular substances to a modified polysaccharide |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1638806A Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 07/13/2005 | CN1638805A Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/13/2005 | CN1638804A Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
| 07/13/2005 | CN1638802A Percutaneous absorption promoters and compositions for treating athlete's foot |
| 07/13/2005 | CN1638798A Antibody-containing solution pharmaceuticals |
| 07/13/2005 | CN1638791A Stable pharmaceutical composition comprising erythropoietin |
| 07/13/2005 | CN1638789A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 07/13/2005 | CN1638788A Stabilized albumin preparaions |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1638779A Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 07/13/2005 | CN1638771A Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 07/13/2005 | CN1638769A Ophthalmic composition comprising ascomycin |
| 07/13/2005 | CN1638764A Eye drops containing tetrazole derivative |
| 07/13/2005 | CN1638752A Pharmaceutical compositions |
| 07/13/2005 | CN1638751A Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers CRP and SAA |
| 07/13/2005 | CN1638749A Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 07/13/2005 | CN1638748A Taste-masked film-type or wafer-type medicinal preparation |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1638746A Colonic release composition |
| 07/13/2005 | CN1638744A Production of starch-gel-based shaped bodies |
| 07/13/2005 | CN1638742A Sustained release preparations and process for producing the same |
| 07/13/2005 | CN1638741A Novel pharmaceutical dosage forms and method for producing same |
| 07/13/2005 | CN1638740A Modified release dosage forms |
| 07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
| 07/13/2005 | CN1638737A Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 07/13/2005 | CN1638736A Composition and methods for treatment of hyperplasia |
| 07/13/2005 | CN1638735A Cubic liquid crystalline compositions and methods for their preparation |
| 07/13/2005 | CN1638732A Sustained release drug formulations containing a carrier peptide |
| 07/13/2005 | CN1638731A Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 07/13/2005 | CN1638730A Formoterol superfine formulation |
| 07/13/2005 | CN1638729A Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 07/13/2005 | CN1638718A Additives and products including oligoesters |
| 07/13/2005 | CN1637020A Polyol-ifn-beta conjugates |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636600A 皮肤外用制剂 External preparation for skin |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/13/2005 | CN1636591A Stabilized pharmaceutical composition in lyophilized form |
| 07/13/2005 | CN1636589A Non-aqueous polar aprotic peptide formulations |
| 07/13/2005 | CN1636577A Vaginal care composition |
| 07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/13/2005 | CN1636561A Use of at-1 receptor antagonist for treating diseases associated with an increase of at-1 receptors |
| 07/13/2005 | CN1636560A Injectable taxane derivative based compositions |
| 07/13/2005 | CN1636553A Volatile proof solid preparation and producing method thereof |
| 07/13/2005 | CN1636551A Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| 07/13/2005 | CN1636545A A composition for external use |
| 07/13/2005 | CN1636544A A composition for external use |
| 07/13/2005 | CN1210400C Methods for making proteins contaniing free cysteine residues |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/13/2005 | CN1210281C Titanium derived compounds, rpeparation an use thereof |
| 07/13/2005 | CN1210190C Injection molded water soluble container |
| 07/13/2005 | CN1210080C Assembly for local administration of solid and semisolid pharmaceutical and use thereof |
| 07/13/2005 | CN1210065C Solid dispersion system with Pranlukast for improving dissolution, and the preparing method thereof |
| 07/13/2005 | CN1210062C Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof |
| 07/13/2005 | CN1210058C Stable concentrated insulin preparations for pulmonary delivery |
| 07/13/2005 | CN1210032C Parenteral formulations comprising carbamazepine or its derivatives |
| 07/13/2005 | CN1210031C Injectable slow-releasing naltrexone microsphere compositions |
| 07/13/2005 | CN1210028C Aqueous liquid preparation |
| 07/13/2005 | CN1210022C Dichlofenac sodium slow-releasing preparation and its preparation method |
| 07/13/2005 | CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/13/2005 | CN1210017C Novel tiotropiumonium-containing inhalation powder |
| 07/12/2005 | US6917616 Method and apparatus for reduction and restoration of data elements pertaining to transmitted data packets in a communications network |
| 07/12/2005 | US6916958 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/12/2005 | US6916941 Crystallization fromn solutions; antidepressant |
| 07/12/2005 | US6916857 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 07/12/2005 | US6916823 Method of treatment of dopamine-related dysfunction |
| 07/12/2005 | US6916794 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916788 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/12/2005 | US6916785 Homogeneous cyclosporin-containing solution |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916491 Fungus inhibiting biological compound |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916488 Hollow capsules with membranes having hydrophobic and hydrophilic segments of block copolymers |